You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

OXYTOCIN 20 USP UNITS IN DEXTROSE 5% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Oxytocin 20 Usp Units In Dextrose 5%, and what generic alternatives are available?

Oxytocin 20 Usp Units In Dextrose 5% is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in OXYTOCIN 20 USP UNITS IN DEXTROSE 5% is oxytocin. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the oxytocin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Oxytocin 20 Usp Units In Dextrose 5%

A generic version of OXYTOCIN 20 USP UNITS IN DEXTROSE 5% was approved as oxytocin by HIKMA on January 10th, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%?
  • What are the global sales for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%?
  • What is Average Wholesale Price for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%?
Summary for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%
Drug patent expirations by year for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%
Recent Clinical Trials for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, Gentofte, CopenhagenN/A
University of Colorado, DenverPhase 2
Karolinska InstitutetPhase 2

See all OXYTOCIN 20 USP UNITS IN DEXTROSE 5% clinical trials

US Patents and Regulatory Information for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott OXYTOCIN 20 USP UNITS IN DEXTROSE 5% oxytocin INJECTABLE;INJECTION 019185-002 Mar 29, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.